 |
Video: What is a Stock Split?
|
 |
Celsion is a clinical stage biotechnology company. Co.'s product pipeline includes GEN-1, a DNA-based immunotherapy for the treatment of ovarian cancer. ThermoDox®, Co.'s proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored development for several cancer indications, which is being managed though Co.'s wholly owned subsidiary, Celsion GmbH. Additionally, Co. has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies and vaccines and other anti-cancer DNA or RNA therapies. Both are synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection. According to our CLSN split history records, CLSN has had 3 splits. | |
 |

CLSN (CLSN) has 3 splits in our CLSN split history database. The first split for CLSN took place on October 29, 2013. This was a 222 for 1000 reverse split, meaning for each 1000 shares of CLSN owned pre-split, the shareholder now owned 222 shares. For example, a 1000 share position pre-split, became a 222 share position following the split. CLSN's second split took place on May 30, 2017. This was a 1 for 14 reverse split, meaning for each 14 shares of CLSN owned pre-split, the shareholder now owned 1 share. For example, a 222 share position pre-split, became a 15.8571428571429 share position following the split. CLSN's third split took place on March 01, 2022. This was a 1 for 15 reverse split, meaning for each 15 shares of CLSN owned pre-split, the shareholder now owned 1 share. For example, a 15.8571428571429 share position pre-split, became a 1.05714285714286 share position following the split.
When a company such as CLSN conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CLSN split history from start to finish, an original position size of 1000 shares would have turned into 1.05714285714286 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CLSN shares, starting with a $10,000 purchase of CLSN, presented on a split-history-adjusted basis factoring in the complete CLSN split history.

Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/03/2013 |
|
End date: |
09/20/2022 |
|
Start price/share: |
$831.60 |
|
End price/share: |
$1.96 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.76% |
|
Average Annual Total Return: |
-49.72% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$23.57 |
|
Years: |
8.80 |
|
|
 |
Date |
Ratio |
10/29/2013 | 222 for 1000 | 05/30/2017 | 1 for 14 | 03/01/2022 | 1 for 15 |
|
 |